Vidacare's bone marrow biopsy system:
This article was originally published in Clinica
Vidacare's new bone marrow biopsy (trephine) system, OnControl, has received 510(k) clearance from the US FDA. OnControl has a lithium-powered driver, and is intended to improve the speed, control, core capture rate, and patient comfort of the bone marrow biopsy procedure. The San Antonio, Texas-based company said that, according to a recent study, the manual procedure - the current standard - causes pain rated as severe to "worst possible" by nearly 20% of patients. The OnControl Biopsy System uses 11 gauge, 102mm or 152mm needles with specialised bi-bevelled cutting tips. It has a biopsy tray designed to simplify needle set access and usage while maintaining a sterile environment, and the cannula features a standard luer-lock connector.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.